4//SEC Filing
Burrows Scott L 4
Accession 0000950170-23-072763
CIK 0001636282other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 6:00 PM ET
Size
5.1 KB
Accession
0000950170-23-072763
Insider Transaction Report
Form 4
Burrows Scott L
Chief Financial Officer
Transactions
- Award
Common Stock
2023-12-22+134,953→ 134,953 total
Footnotes (1)
- [F1]Represents 134,953 restricted stock units ("RSUs") granted under the Spyre Therapeutics, Inc. 2016 Equity Incentive Plan, as Amended and Restated. Each RSU represents a contingent right to receive, upon vesting, one share of common stock, par value $0.0001 per share, of the Issuer. The RSUs vest as to one-fourth on each anniversary of September 1, 2023, subject to the Reporting Person's continued employment with the Issuer.
Documents
Issuer
Spyre Therapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001853327
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 6:00 PM ET
- Size
- 5.1 KB